Therefore, understanding the role of GCNT2 in modulating the PI3K/Akt pathway through glycosylation presents an exciting avenue for developing novel interventions aimed at alleviating the multifaceted challenges faced by women with PCOS (52). This evidence concerns the gene GCNT2 and polycystic ovary syndrome.